Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Atorvastatin on Endothelial Function, Vascular and Myocardial Redox State in High Cardiovascular Risk Patients

NCT01013103 is registered in ClinicalTrials.gov with Hippocration General Hospital as lead sponsor.

NCT NCT01013103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01013103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Atorvastatin on Endothelial Function, Vascular and Myocardial Redox State in High Cardiovascular Risk Patients
Lead sponsor
Hippocration General Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2007
Completion date
February 29, 2012
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, coronary artery disease, endothelial dysfunction, hmg-coa reductase inhibitor toxicity, oxidative stress